S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.

Bibliographic Details
Main Authors: Thomas Ernst, Philipp Le Coutre, Martina Crysandt, Tim H Brümmendorf, Georg-Nikolaus Franke, Thomas Illmer, Andreas Burchert, Fabian Lang, Susanne Saussele, Lino Lars Teichmann, Markus Radsak, Stefan Krause, Jenny Rinke, Christian Fabisch, Thomas Lang, Markus Pfirrmann, Andreas Hochhaus
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000967536.34543.a6
_version_ 1827331167628558336
author Thomas Ernst
Philipp Le Coutre
Martina Crysandt
Tim H Brümmendorf
Georg-Nikolaus Franke
Thomas Illmer
Andreas Burchert
Fabian Lang
Susanne Saussele
Lino Lars Teichmann
Markus Radsak
Stefan Krause
Jenny Rinke
Christian Fabisch
Thomas Lang
Markus Pfirrmann
Andreas Hochhaus
author_facet Thomas Ernst
Philipp Le Coutre
Martina Crysandt
Tim H Brümmendorf
Georg-Nikolaus Franke
Thomas Illmer
Andreas Burchert
Fabian Lang
Susanne Saussele
Lino Lars Teichmann
Markus Radsak
Stefan Krause
Jenny Rinke
Christian Fabisch
Thomas Lang
Markus Pfirrmann
Andreas Hochhaus
author_sort Thomas Ernst
collection DOAJ
first_indexed 2024-03-07T16:32:12Z
format Article
id doaj.art-0f3d81dfcbbb4aa0ae6d03ccea5bcb77
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:32:12Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-0f3d81dfcbbb4aa0ae6d03ccea5bcb772024-03-03T10:10:15ZengWileyHemaSphere2572-92412023-08-017e34543a610.1097/01.HS9.0000967536.34543.a6202308003-00058S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.Thomas Ernst0Philipp Le Coutre1Martina Crysandt2Tim H Brümmendorf3Georg-Nikolaus Franke4Thomas Illmer5Andreas Burchert6Fabian Lang7Susanne Saussele8Lino Lars Teichmann9Markus Radsak10Stefan Krause11Jenny Rinke12Christian Fabisch13Thomas Lang14Markus Pfirrmann15Andreas Hochhaus161 Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germany2 Charité Universitätsmedizin Berlin, Berlin, Germany3 Universitätsklinikum Aachen, Aachen, Germany3 Universitätsklinikum Aachen, Aachen, Germany4 Universitätsklinikum Leipzig, Leipzig, Germany5 GOKOS GmbH, Dresden, Germany6 Universitätsklinikum Gießen und Marburg, Marburg, Germany7 Klinikum der Goethe Universität Frankfurt, Frankfurt, Germany8 Universitätsmedizin Mannheim, Mannheim, Germany9 Universitätsklinikum Bonn, Bonn, Germany10 Universitätsmedizin Mainz, Mainz, Germany11 Universitätsklinikum Erlangen, Erlangen, Germany1 Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germany1 Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germany12 Ludwig-Maximilians-Universität, München, Germany12 Ludwig-Maximilians-Universität, München, Germany1 Universitätsklinikum Jena, Klinik für Innere Medizin II, Jena, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000967536.34543.a6
spellingShingle Thomas Ernst
Philipp Le Coutre
Martina Crysandt
Tim H Brümmendorf
Georg-Nikolaus Franke
Thomas Illmer
Andreas Burchert
Fabian Lang
Susanne Saussele
Lino Lars Teichmann
Markus Radsak
Stefan Krause
Jenny Rinke
Christian Fabisch
Thomas Lang
Markus Pfirrmann
Andreas Hochhaus
S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
HemaSphere
title S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
title_full S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
title_fullStr S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
title_full_unstemmed S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
title_short S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
title_sort s156 frontline asciminib combination in chronic phase chronic myeloid leukemia patients the fascination trial
url http://journals.lww.com/10.1097/01.HS9.0000967536.34543.a6
work_keys_str_mv AT thomasernst s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT philipplecoutre s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT martinacrysandt s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT timhbrummendorf s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT georgnikolausfranke s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT thomasillmer s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT andreasburchert s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT fabianlang s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT susannesaussele s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT linolarsteichmann s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT markusradsak s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT stefankrause s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT jennyrinke s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT christianfabisch s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT thomaslang s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT markuspfirrmann s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial
AT andreashochhaus s156frontlineasciminibcombinationinchronicphasechronicmyeloidleukemiapatientsthefascinationtrial